TissueLabs is a Swiss biotech pioneering biofabrication, developing 3D bioprinters, tissue-specific hydrogels, and engineered tissues. Supporting research, drug testing, and regenerative medicine, its long-term vision is to create the first transplantable bioartificial heart.
Products, services, technology
3D Bioprinters
- TissueStart™ 3D Bioprinter
- TissueRay™ 3D Bioprinter
Tissue-specific Biomaterials
- MatriXpec™ Hydrogels
- MatriSponge™ Bioactive Scaffolds
- TissueCoat™ ECM Surface Coating
Cooperation possibilities
We offer collaboration opportunities in biofabrication, including partnerships for drug development, regenerative medicine, and tissue engineering research.
- https://www.tissuelabs.com
- +41 78 223 67 25
- Send an email
- Gabriel Liguori
Some insights
TissueLabs empowers scientists to create human tissues in the lab, accelerating drug discovery, reducing animal testing, and advancing regenerative medicine. Our ultimate goal is to develop bioartificial organs, addressing the global shortage of donor transplants.
We are proud of TissueLabs because we are pushing the boundaries of science to create lab-grown tissues and, one day, bioartificial organs. We help researchers develop better treatments, reduce animal testing, and bring hope to patients needing life-saving transplants.
Our team excels in biofabrication, biomaterials, and tissue engineering, blending scientific expertise with product development. We seek to strengthen regulatory, clinical translation, and commercial capabilities to accelerate our path toward implantable tissues.
They’d say we are building hearts in the lab! They know we work to create tissues and organs using 3D printing, helping doctors test new treatments and, one day, making transplant organs so people don’t have to wait for a donor to survive.
The Swiss biotech ecosystem can best support us by fostering connections with pharma, hospitals, and research institutions, facilitating regulatory guidance for advanced therapies, and expanding funding opportunities tailored to deep-tech and regenerative medicine startups.
We seek to connect with pharmaceutical companies, biotech firms, research hospitals, and academic institutions interested in drug discovery, regenerative medicine, and biofabrication, as well as investors and strategic partners in life sciences and biotech.